Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 11.84
+0.12 (1.02%)
Jul 29, 2026, 3:00 PM CST
SHA:600267 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,855 | 1,292 | 1,498 | 1,587 | 1,399 | 1,296 |
Trading Asset Securities | 1.99 | 2.37 | - | 0.29 | - | 3.05 |
Cash & Short-Term Investments | 1,857 | 1,295 | 1,498 | 1,587 | 1,399 | 1,299 |
Cash Growth | 16.87% | -13.56% | -5.63% | 13.45% | 7.70% | -36.93% |
Accounts Receivable | 785.3 | 1,904 | 1,918 | 2,066 | 2,553 | 2,239 |
Other Receivables | 184.38 | 196.09 | 203.59 | 411.65 | 249.57 | 414.04 |
Receivables | 969.68 | 2,101 | 2,122 | 2,478 | 2,802 | 2,653 |
Inventory | 1,356 | 1,687 | 1,795 | 1,957 | 1,914 | 2,023 |
Other Current Assets | 190.2 | 328.94 | 247.25 | 337.33 | 294.12 | 389.29 |
Total Current Assets | 4,373 | 5,411 | 5,661 | 6,359 | 6,409 | 6,364 |
Property, Plant & Equipment | 6,877 | 7,061 | 7,566 | 8,252 | 9,101 | 9,754 |
Long-Term Investments | 1,503 | 1,484 | 1,450 | 1,415 | 1,482 | 1,383 |
Goodwill | - | - | - | - | - | 1.42 |
Other Intangible Assets | 833.24 | 848.67 | 946.66 | 1,073 | 1,337 | 1,419 |
Long-Term Deferred Tax Assets | 108.84 | 146.32 | 175.22 | 179.62 | 96.17 | 118.58 |
Long-Term Deferred Charges | 31.38 | 7.66 | 53.28 | 176.26 | 194.45 | 187.17 |
Other Long-Term Assets | 86.42 | 92.72 | 119.68 | 159.02 | 158.75 | 146.69 |
Total Assets | 13,813 | 15,052 | 15,972 | 17,613 | 18,778 | 19,374 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 795.87 | 1,007 | 1,079 | 1,144 | 1,303 | 1,037 |
Accrued Expenses | 325.37 | 1,381 | 1,409 | 1,612 | 1,585 | 1,617 |
Short-Term Debt | 1,353 | 1,980 | 2,161 | 2,157 | 3,005 | 4,491 |
Current Portion of Long-Term Debt | 785.88 | 740.84 | 908.83 | 1,048 | 313.86 | 557.01 |
Current Portion of Leases | - | 14.82 | 14.65 | 10.69 | 10.75 | 11.64 |
Current Income Taxes Payable | 217.08 | 141.49 | 59.28 | 34.74 | 59.83 | 44.95 |
Current Unearned Revenue | 63.55 | 81.93 | 91.49 | 106.5 | 119.05 | 268.42 |
Other Current Liabilities | 845.9 | 486.58 | 414.08 | 469.87 | 736.82 | 757.82 |
Total Current Liabilities | 4,387 | 5,833 | 6,138 | 6,584 | 7,133 | 8,785 |
Long-Term Debt | 35 | 155 | 1,007 | 2,368 | 3,057 | 2,758 |
Long-Term Leases | 48.96 | 49.41 | 58.31 | 29.15 | 32.38 | 37.56 |
Long-Term Unearned Revenue | 130.67 | 137.17 | 164.58 | 185.96 | 207.15 | 216.28 |
Long-Term Deferred Tax Liabilities | 15.98 | 25.07 | 25.25 | 22.63 | 17.97 | 20.73 |
Other Long-Term Liabilities | - | - | - | 74.08 | - | 211.12 |
Total Liabilities | 4,618 | 6,200 | 7,393 | 9,264 | 10,448 | 12,029 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,199 | 1,199 | 1,199 | 1,208 | 1,198 | 1,196 |
Additional Paid-In Capital | 4,345 | 4,332 | 4,291 | 4,346 | 4,163 | 3,511 |
Retained Earnings | 3,789 | 3,433 | 3,138 | 2,536 | 2,829 | 2,500 |
Treasury Stock | -393.5 | -367.28 | -299.4 | -341.15 | -549.56 | -337.73 |
Comprehensive Income & Other | 9.16 | 10.74 | 13.12 | 353.08 | 439.19 | 433.98 |
Total Common Equity | 8,948 | 8,607 | 8,341 | 8,102 | 8,079 | 7,303 |
Minority Interest | 247.29 | 244.44 | 237.66 | 247.44 | 251.1 | 42.23 |
Shareholders' Equity | 9,195 | 8,852 | 8,579 | 8,349 | 8,330 | 7,346 |
Total Liabilities & Equity | 13,813 | 15,052 | 15,972 | 17,613 | 18,778 | 19,374 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,223 | 2,940 | 4,150 | 5,613 | 6,419 | 7,855 |
Net Cash (Debt) | -366.14 | -1,645 | -2,652 | -4,026 | -5,020 | -6,556 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.31 | -1.40 | -2.29 | -3.46 | -4.31 | -5.79 |
Filing Date Shares Outstanding | 1,158 | 1,161 | 1,169 | 1,178 | 1,188 | 1,196 |
Total Common Shares Outstanding | 1,158 | 1,161 | 1,169 | 1,189 | 1,172 | 1,196 |
Working Capital | -14.28 | -422.65 | -476.51 | -224.79 | -723.95 | -2,421 |
Book Value Per Share | 7.72 | 7.41 | 7.14 | 6.81 | 6.89 | 6.11 |
Tangible Book Value | 8,115 | 7,759 | 7,395 | 7,029 | 6,742 | 5,883 |
Tangible Book Value Per Share | 7.00 | 6.68 | 6.33 | 5.91 | 5.75 | 4.92 |
Buildings | - | 6,119 | 6,032 | 5,969 | 5,669 | 5,608 |
Machinery | - | 9,282 | 9,165 | 8,660 | 8,445 | 8,115 |
Construction In Progress | - | 317.51 | 216.84 | 688.39 | 1,244 | 1,541 |